Product News

Share this article:

Forest Laboratories and Cypress Bioscience launched Savella, a selective serotonin and norepinephrine dual reuptake inhibitor, for fibromyalgia. The product will be available in drug stores April 28.

 

Sanofi-Aventis launched Apidra SoloSTAR, an insulin pen, indicated for adults and children 4 years and older, with type 1 diabetes or adults with type 2 diabetes.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Janssen recruits Debbie Allen for T2 Diabetes

Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.

Pfizer seeks wider Xeljanz indication

The company expects to file an sNDA for plaque psoriasis next year.

Recalls dent Stryker Q1 earnings

Sales rose 5% compared to the same period last year.